Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 7/20 | 0.54 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ICMT | O60725 | 4/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6091680 | 0.93 | PPARG (0.61) | PPARGF2RL3KMT2AICMTPLA2G2A | |
| SCHEMBL6090091 | 0.91 | PPARG (0.57) | PPARGF2RL3ICMTMAOB | |
| SCHEMBL6092537 | 0.90 | PPARG (0.59) | PPARGF2RL3MAOB | |
| SCHEMBL6089564 | 0.86 | PPARG (0.54) | PPARGF2RL3ICMTPLA2G2A | |
| SCHEMBL6857727 | 0.86 | PPARG (0.72) | PPARGF2RL3KMT2A | |
| SCHEMBL6089789 | 0.84 | PPARG (0.48) | PPARGICMTMAOB | |
| SCHEMBL6093344 | 0.83 | PPARG (0.65) | PPARGF2RL3ICMTPLA2G2A | |
| SCHEMBL6091159 | 0.83 | PPARG (0.65) | PPARGF2RL3ICMT | |
| SCHEMBL6091286 | 0.82 | PPARG (0.51) | PPARGICMTMAOB | |
| SCHEMBL5772496 | 0.80 | PPARG (0.57) | PPARGF2RL3ICMTPLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160879-A1 | Indoles useful in the treatment of inflammation | BIOLIPOX AB (SE) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160879-A1 | Indoles useful in the treatment of inflammation | IDO1, PTGS1, IDO2 | PPARG 481/4885F2RL3 128/4885KMT2A 3542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.